The Dean’s Swine Flu Pick is FDA Approved
November 4th, 2009 at 1:17 pm Posted by The Dean
This week, The Dean told the CollegeStock Community that there’s an upcoming Ivy League Stock Pick that falls into the category of swine flu stocks. This company has a medical device that kills airborne bacteria and has been approved by the FDA.
Better yet, this Ivy Leaguer will be introduced to The Dean’s Honors Class on the first day of the company’s initial public offering—that’s right an IPO.
The Dean believes this company’s product has big potential this winter season, especially because of the increased media coverage and alerts from the U.S. government about the deadly potential of swine flu. Naturally, the influenza virus, colds and respiratory illnesses are more common during the winter months. Well, here we are in the beginning of November and the flu season has yet to begin.
The ability for this company’s product to kill 99% of airborne bacteria and germs makes its potential even greater with the swine flu pandemic heating up as we come closer and closer to the December to March seasonal flu peak. The Dean recently taught the CollegeStock Community about the potential dangers of swine flu and the possibility of a pandemic vaccine not being available until after January.
An important fact to remember about The Dean’s upcoming swine flu pick is that the company’s product isn’t in development phase or pending FDA approval. No, this company’s product has already received FDA approval and is currently being marketed—The Dean thinks this could be HUGE.
The Dean’s certain that the CollegeStock Community remembers $BONU, a chemical based technology company trying to commercialize its two products which neutralize toxins, bacteria, viruses and more. $BONU was The Dean’s first swine flu pick and The Dean’s Honors Class made a potential profit of more than 800% on this Ivy League Stock Pick.
The Dean believes the height of the swine flu chaos has not even begun and his upcoming swine flu pick will have the added excitement of an IPO and an FDA approved product to fuel its momentum.
Markets Research Reports estimates that the global swine flu market will exceed $7 billion by 2011—an increase of more than 200% from October’s estimate.
Based on the huge success of $BONU and the large market potential for an FDA approved swine flu product, The Dean has plenty of reasons to believe this upcoming Ivy League Stock Pick could be tremendous.
Dean, I wish you would not waste your credibility on this stock. Unless you plan on hanging out with Tuberculosis patients, nobody will need an FDA approved airborne bacteria killing air purifier. Swine Flu H1N1′09 is spread by particulates transfered on to a mucus membrane, and it is not now, nor ever likely to mutate into an aerosol virus.
What stock are you talking about?
I get what youre saying pack but I was thinking that if the device killed germs in the air then they couldn’t land on surfaces. So if there were germs on a surface like h1n1 then they would be killed by the mist from this product?
I could elaborate – but as Dean would say “you are responsible to do your own due diligence”. In my opinion; expecting people to buy FDA approved air filters for swine flu, is sort of like expected people to buy Police grade flashlights for self defense…